HSP90AA1 and Alzheimer disease: Here, systemic, or local effects of the Hsp90 inhibitor STA-9090 (Ganetespib), targeting specifically ATP-binding domain of Hsp90, on development of the experimental mouse model of dinitrochlorobenzene (DNCB)-induced AD were studied.